1. American Cancer Society, 2023. Cancer facts and figures 2023. https://www.cancer.org/research/cancer-facts-statistics/all-cancer-facts-figures/2023-cancer-facts-figures.html (accessed 5 March 2024).
2. Bevacizumab or PARP-inhibitors maintenance therapy for platinum-sensitive recurrent ovarian cancer: a network meta-analysis;Bartoletti;Int. J. Mol. Sci.,2020
3. Incorporation of bevacizumab in the primary treatment of ovarian cancer;Burger;N. Engl. J. Med.,2011
4. Real-world outcomes associated with poly(ADP-ribose) polymerase inhibitor monotherapy maintenance in patients with primary advanced ovarian cancer;Chan;Am. J. Clin. Oncol.,2023
5. Association of multiple high-risk factors on observed outcomes in real-world patients with advanced ovarian cancer treated with first-line therapy;Chase;JCO Clin. Cancer Inform.,2023